Defiance ETFs’s Intuitive Surgical ISRG Stock Holding History

Defiance ETFs’s Portfolio ISRG Stock Details ISRG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$575K	Buy	1,428 +263	+23%	+$115K	0.01%	268
2026 Q1	$537K	Buy	+1,165	New	+$589K	0.01%	260

Other funds holding ISRG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Defiance ETFs's ISRG Position: Q2 2026 in Review

Defiance ETFs increased its Intuitive Surgical (ISRG) stake by 23% in Q2 2026, buying an estimated $115K and bringing the position to 1,428 shares worth $575K. The position accounts for 0.01% of the portfolio, ranked #268.

Defiance ETFs first reported a position in ISRG in Q1 2026 and has held it in 2 quarters since. 2,236 funds tracked by Wall St. Rank hold ISRG as of Q2 2026.

Defiance ETFs held 1,428 shares of Intuitive Surgical worth $575K as of Q2 2026.
Defiance ETFs bought 263 Intuitive Surgical shares in Q2 2026, an estimated $115K.
Intuitive Surgical made up 0.01% of Defiance ETFs's portfolio in Q2 2026, its #268 holding.
Defiance ETFs first reported a position in Intuitive Surgical in Q1 2026 and has held it in 2 quarters since.
2,236 funds tracked by Wall St. Rank held Intuitive Surgical as of Q2 2026.

Based on Defiance ETFs's 13F filing for Q2 2026, filed 14 Aug 2026.